| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.25853 |
| P698 | PubMed publication ID | 24757109 |
| P50 | author | Trevor W. Robbins | Q7839400 |
| Roshan Cools | Q30131223 | ||
| P2860 | cites work | The role of the basal ganglia in learning and memory: insight from Parkinson's disease | Q26851807 |
| Neural systems engaged by planning: a PET study of the Tower of London task | Q28111463 | ||
| Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| Getting formal with dopamine and reward | Q29618725 | ||
| The debate over dopamine's role in reward: the case for incentive salience | Q29618738 | ||
| Reversal learning in Parkinson's disease depends on medication status and outcome valence. | Q52016714 | ||
| Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. | Q52170683 | ||
| Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. | Q52222727 | ||
| The performance on learning tasks of patients in the early stages of Parkinson's disease. | Q52247786 | ||
| Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. | Q52248519 | ||
| Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. | Q53187673 | ||
| An Essay on the Shaking Palsy | Q56430868 | ||
| Cognitive deficits in the early stages of Parkinson's disease | Q48800336 | ||
| The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease | Q48891136 | ||
| The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort | Q50249993 | ||
| Neuropsychological profile of patients with Parkinson's disease without dementia. | Q51950566 | ||
| Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn? | Q51992268 | ||
| Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. | Q52002397 | ||
| Memory and executive function impairment predict dementia in Parkinson's disease. | Q52009084 | ||
| Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition | Q30482965 | ||
| Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease | Q30559309 | ||
| Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens | Q30856847 | ||
| Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. | Q30982993 | ||
| Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease | Q33647691 | ||
| Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors | Q33657211 | ||
| Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia | Q33963430 | ||
| Rivastigmine for dementia associated with Parkinson's disease | Q33983707 | ||
| Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients | Q34036887 | ||
| A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease | Q34177042 | ||
| Fronto-striatal cognitive deficits at different stages of Parkinson's disease | Q34296796 | ||
| Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. | Q34309398 | ||
| Visuospatial memory deficits at different stages of Parkinson's disease | Q34354414 | ||
| Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism | Q34392452 | ||
| Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease | Q34423750 | ||
| Memory systems of the brain: a brief history and current perspective | Q34551600 | ||
| A role for dopamine in temporal decision making and reward maximization in parkinsonism | Q34629659 | ||
| Procedural learning and neostriatal dysfunction in man. | Q34684107 | ||
| The neuropathological basis for depression in Parkinson's disease | Q34764454 | ||
| Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
| L-dopa impairs learning, but spares generalization, in Parkinson's disease | Q35113281 | ||
| Neuropsychiatric non-motor aspects of Parkinson’s disease | Q35518017 | ||
| Reliance on habits at the expense of goal-directed control following dopamine precursor depletion | Q35644112 | ||
| Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease | Q35986681 | ||
| Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task | Q36037387 | ||
| A systematic review of prevalence studies of dementia in Parkinson's disease | Q36206067 | ||
| Neuropsychological prediction of dementia in Parkinson's disease | Q36317822 | ||
| A role for mesencephalic dopamine in activation: commentary on Berridge (2006). | Q36594929 | ||
| Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. | Q36834550 | ||
| Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. | Q37196231 | ||
| Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions | Q37338753 | ||
| Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients | Q37397116 | ||
| Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. | Q37419211 | ||
| Rule-based category learning in patients with Parkinson's disease | Q37475979 | ||
| Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway | Q37543216 | ||
| Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study | Q37593269 | ||
| Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action | Q37602505 | ||
| Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease | Q37794466 | ||
| Contributions of the ventromedial prefrontal cortex to goal-directed action selection | Q37965254 | ||
| The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort | Q38378476 | ||
| Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability | Q38475352 | ||
| 'Subcortical dementia': the neuropsychological evidence | Q39486755 | ||
| Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey | Q39680193 | ||
| Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease | Q40445234 | ||
| Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness | Q40938032 | ||
| 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa | Q41437567 | ||
| Temporal ordering and short-term memory deficits in Parkinson's disease | Q41438038 | ||
| Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow | Q41476240 | ||
| A neural model of hippocampal-striatal interactions in associative learning and transfer generalization in various neurological and psychiatric patients | Q41859547 | ||
| Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study | Q41960165 | ||
| Dopamine enhances model-based over model-free choice behavior | Q42272537 | ||
| Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease | Q42628290 | ||
| Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex | Q43608350 | ||
| L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction | Q43643543 | ||
| Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands | Q43800068 | ||
| Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. | Q43901509 | ||
| Parkinson's disease. Cognitive changes in relation to treatment response | Q44176896 | ||
| L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease | Q44505615 | ||
| A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients | Q44986467 | ||
| Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism | Q45010955 | ||
| By carrot or by stick: cognitive reinforcement learning in parkinsonism | Q45140702 | ||
| Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance? | Q45258267 | ||
| Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease. | Q45300296 | ||
| A neostriatal habit learning system in humans. | Q45979314 | ||
| Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. | Q46384404 | ||
| Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease | Q46814956 | ||
| Remote memory function in Alzheimer's disease and Parkinson's disease | Q47348981 | ||
| Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 | ||
| Internal versus external cues and the control of attention in Parkinson's disease | Q48091220 | ||
| Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study | Q48115841 | ||
| Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study | Q48123682 | ||
| Apathy blunts neural response to money in Parkinson's disease | Q48148418 | ||
| Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease | Q48180786 | ||
| Habitual versus goal-directed action control in Parkinson disease | Q48214291 | ||
| Dissociating hippocampal versus basal ganglia contributions to learning and transfer | Q48345239 | ||
| The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease | Q48435168 | ||
| Motivation, reward, and Parkinson's disease: influence of dopatherapy | Q48453518 | ||
| L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease | Q48472006 | ||
| A subcortico-cortical cholinergic system is affected in Parkinson's disease | Q48704788 | ||
| Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease | Q48737270 | ||
| Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss | Q48784158 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cognitive neuroscience | Q1138951 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 597-607 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective | |
| P478 | volume | 29 |
| Q50090251 | A model-based quantification of action control deficits in Parkinson's disease |
| Q47377546 | A supramodal role of the basal ganglia in memory and motor inhibition: Meta-analytic evidence. |
| Q38663184 | Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease |
| Q38845488 | Alexithymia in Parkinson's disease: a point of view on current evidence |
| Q48279927 | Antisaccades and executive dysfunction in PD: Two sides of the same coin? |
| Q96308586 | Apathy is associated with white matter network disruption and specific cognitive deficits in Parkinson's disease |
| Q28084637 | Assessment of cognitive safety in clinical drug development |
| Q40765887 | Associations of pain and depression with marital status in patients diagnosed with Parkinson's disease. |
| Q40460924 | Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment. |
| Q38675620 | Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease. |
| Q48051245 | Cognitive Flexibility in Primary Dystonia |
| Q39023945 | Cognitive Training in Parkinson's Disease |
| Q28073680 | Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014 |
| Q38597726 | Cognitive flexibility and its electrophysiological correlates in Gilles de la Tourette syndrome. |
| Q38416865 | Cognitive function in the early phase of Parkinson's disease, a five-year follow-up |
| Q28071285 | Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging |
| Q38712774 | Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients |
| Q26777668 | Cognitive training in Parkinson disease: A systematic review and meta-analysis |
| Q47654564 | Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease |
| Q33785754 | Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson's Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task. |
| Q37606920 | Development and function of the midbrain dopamine system: what we know and what we need to |
| Q48509840 | Diminished EEG habituation to novel events effectively classifies Parkinson's patients |
| Q37723968 | Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning. |
| Q48410373 | Disentangling the Role of Cortico-Basal Ganglia Loops in Top-Down and Bottom-Up Visual Attention: An Investigation of Attention Deficits in Parkinson Disease |
| Q47824693 | Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease. |
| Q37494873 | Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review |
| Q35795738 | Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders |
| Q27317224 | Dysfunctional counting of mental time in Parkinson's disease. |
| Q58735472 | Enhanced motivation of cognitive control in Parkinson's disease |
| Q52322966 | Gene expression links functional networks across cortex and striatum. |
| Q36343417 | Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease |
| Q64103399 | Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease |
| Q36289067 | Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults |
| Q60302613 | Impaired cognitive modification for estimating time duration in Parkinson's disease |
| Q37447122 | Increase of EEG Spectral Theta Power Indicates Higher Risk of the Development of Severe Cognitive Decline in Parkinson's Disease after 3 Years |
| Q26860706 | Individual differences in approach-avoidance aptitude: some clues from research on Parkinson's disease |
| Q47972063 | Intact working memory in non-manifesting LRRK2 carriers--an fMRI study |
| Q42110375 | Introduction: the importance of cognition in movement disorders |
| Q51765974 | Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease. |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q64863852 | Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson's Disease With and Without Depression (History) |
| Q33881847 | Mind-Body Practice Changes Fractional Amplitude of Low Frequency Fluctuations in Intrinsic Control Networks |
| Q42181834 | Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism |
| Q39144600 | Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. |
| Q38724991 | Neurophysiology of rule switching in the corticostriatal circuit |
| Q40253420 | Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis |
| Q41747219 | Neuroscience: Impaired Decision-Making in Parkinson's Disease |
| Q40058208 | Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests |
| Q46580980 | Optogenetic Stimulation of Frontal D1 Neurons Compensates for Impaired Temporal Control of Action in Dopamine-Depleted Mice. |
| Q31080551 | Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association? |
| Q64873993 | Paradoxical Decision-Making: A Framework for Understanding Cognition in Parkinson's Disease |
| Q42269525 | Patients with Parkinson's Disease Show Impaired Use of Priors in Conditions of Sensory Uncertainty |
| Q48090161 | Prefrontal Dopamine D1 and D2 Receptors Regulate Dissociable Aspects of Decision Making via Distinct Ventral Striatal and Amygdalar Circuits. |
| Q47402058 | Prospective memory functioning in individuals with Parkinson's disease: a systematic review |
| Q33885120 | Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effects |
| Q30983855 | Resting-state functional brain networks in Parkinson's disease. |
| Q35808249 | Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation |
| Q38958979 | Smoking history is associated to cognitive impairment in Parkinson's disease |
| Q91610778 | Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk |
| Q45956226 | Telerehabilitation in Parkinson's disease: Influence of cognitive status. |
| Q94959580 | The Challenge of Managing Parkinson's Disease Patients during the COVID-19 Pandemic |
| Q60050592 | The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration |
| Q27321077 | What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease? |
Search more.